Ratings by Morgan Stanley (Kallum Titchmarsh)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/13/2026 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 10/13/2026 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/13/2026 | Mettler-Toledo | MTD | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/13/2026 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 10/13/2026 | GRAIL, Inc. | GRAL | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/13/2026 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 10/13/2026 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 10/13/2026 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 10/13/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/13/2026 | 10X Genomics | TXG | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/22/2026 | West Pharmaceutical | WST | Upgrade | Overweight (Equalweight) |
361.78 (392.15) |
8.39% | Details | |
| 9/17/2026 | IQVIA Holdings | IQV | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/3/2026 | MiniMed Group | MMED | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2026 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 8/10/2026 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2026 | Waters Corp. | WAT | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/4/2026 | Veracyte, Inc | VCYT | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/4/2026 | Mettler-Toledo | MTD | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/4/2026 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/29/2026 | IQVIA Holdings | IQV | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/27/2026 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 7/22/2026 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 7/9/2026 | West Pharmaceutical | WST | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/9/2026 | Waters Corp. | WAT | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/9/2026 | Veracyte, Inc | VCYT | Maintain | Underweight (N/A) |
|
Details | ||
| 7/9/2026 | Personalis | PSNL | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/9/2026 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 7/9/2026 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 7/9/2026 | Charles River Labs | CRL | Maintain | Overweight (N/A) |
|
Details | ||
| 7/9/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/9/2026 | 10X Genomics | TXG | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/17/2026 | IQVIA Holdings | IQV | Downgrade | Equalweight (Overweight) |
179.17 (279.36) |
55.92% | Details | |
| 6/17/2026 | Charles River Labs | CRL | Upgrade | Overweight (Equalweight) |
184.79 (345.37) |
86.9% | Details | |
| 5/12/2026 | Personalis | PSNL | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/12/2026 | Mettler-Toledo | MTD | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/12/2026 | Cytek Biosciences Inc | CTKB | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/12/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/12/2026 | 10X Genomics | TXG | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/7/2026 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 4/27/2026 | West Pharmaceutical | WST | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/27/2026 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 4/22/2026 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 3/31/2026 | MiniMed Group | MMED | New Coverage | Overweight (N/A) |
14.35 (18.34) |
27.8% | Details | |
| 3/6/2026 | Stevanato Group S.p.A. | STVN | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/5/2026 | Veracyte, Inc | VCYT | Maintain | Underweight (N/A) |
|
Details | ||
| 3/4/2026 | Personalis | PSNL | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/3/2026 | Tempus AI Inc | TEM | Maintain | Overweight (N/A) |
|
Details | ||
| 3/2/2026 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/2/2026 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2026 | GRAIL, Inc. | GRAL | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/23/2026 | Waters Corp. | WAT | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/19/2026 | Inspire Medical Systems | INSP | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/11/2026 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 2/9/2026 | Mettler-Toledo | MTD | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/2/2025 | SI-BONE Inc. | SIBN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/2/2025 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 12/2/2025 | Alphatec Holdings | ATEC | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/2/2025 | Inspire Medical Systems | INSP | Downgrade | Equalweight (Overweight) |
126.34 (71.11) |
-43.72% | Details | |
| 12/2/2025 | Agilent | A | New Coverage | Overweight (N/A) |
153.50 (173.07) |
12.75% | Details | |
| 12/2/2025 | Cytek Biosciences Inc | CTKB | New Coverage | Equalweight (N/A) |
5.65 (5.59) |
-1.06% | Details | |
| 12/2/2025 | Stevanato Group S.p.A. | STVN | New Coverage | Equalweight (N/A) |
23.36 (19.49) |
-16.57% | Details | |
| 12/2/2025 | 10X Genomics | TXG | New Coverage | Equalweight (N/A) |
18.81 (71.55) |
280.38% | Details | |
| 12/2/2025 | Waters Corp. | WAT | New Coverage | Equalweight (N/A) |
403.42 (453.67) |
12.46% | Details | |
| 12/2/2025 | Veracyte, Inc | VCYT | New Coverage | Equalweight (N/A) |
47.34 (47.93) |
1.25% | Details | |
| 12/2/2025 | Personalis | PSNL | New Coverage | Equalweight (N/A) |
10.73 (15.85) |
47.72% | Details | |
| 12/2/2025 | GRAIL, Inc. | GRAL | New Coverage | Equalweight (N/A) |
110.39 (132.55) |
20.07% | Details | |
| 12/2/2025 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Equalweight (N/A) |
19.66 (25.51) |
29.76% | Details | |
| 12/2/2025 | Tempus AI Inc | TEM | New Coverage | Overweight (N/A) |
77.93 (67.62) |
-13.23% | Details | |
| 12/2/2025 | Natera | NTRA | New Coverage | Overweight (N/A) |
238.81 (403.95) |
69.15% | Details | |
| 12/2/2025 | Guardant Health | GH | New Coverage | Overweight (N/A) |
108.42 (169.08) |
55.95% | Details | |
| 12/2/2025 | Thermo Fisher Scientific | TMO | New Coverage | Overweight (N/A) |
590.83 (673.82) |
14.05% | Details | |
| 12/2/2025 | Charles River Labs | CRL | New Coverage | Equalweight (N/A) |
178.14 (184.79) |
3.73% | Details | |
| 12/2/2025 | IQVIA Holdings | IQV | New Coverage | Overweight (N/A) |
230.01 (179.17) |
-22.1% | Details | |
| 12/2/2025 | Danaher | DHR | New Coverage | Overweight (N/A) |
226.78 (230.50) |
1.64% | Details | |
| 12/2/2025 | West Pharmaceutical | WST | New Coverage | Equalweight (N/A) |
277.25 (361.78) |
30.49% | Details | |
| 12/2/2025 | Mettler-Toledo | MTD | New Coverage | Equalweight (N/A) |
1476.72 (1670.29) |
13.11% | Details | |
| 11/10/2025 | Alphatec Holdings | ATEC | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/14/2025 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2025 | SI-BONE Inc. | SIBN | Maintain | Overweight (N/A) |
|
Details | ||
| 7/31/2025 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/15/2025 | Inspire Medical Systems | INSP | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2025 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 2/27/2025 | Alphatec Holdings | ATEC | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/19/2025 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/11/2025 | Inspire Medical Systems | INSP | Maintain | Overweight (N/A) |
|
Details | ||
| 12/2/2024 | SI-BONE Inc. | SIBN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/2/2024 | Alphatec Holdings | ATEC | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/2/2024 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/2/2024 | Nevro Corp | NVRO | Downgrade | Underweight (Equalweight) |
4.60 (5.84) |
26.96% | Details | |
| 12/2/2024 | Globus Medical | GMED | Upgrade | Overweight (Equalweight) |
85.61 (81.41) |
-4.91% | Details | |
| 12/2/2024 | Embecta | EMBC | Upgrade | Overweight (Underweight) |
20.83 (6.71) |
-67.79% | Details | |
| 11/5/2024 | Inspire Medical Systems | INSP | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2024 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/31/2024 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/15/2024 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/15/2024 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/15/2024 | Inspire Medical Systems | INSP | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2024 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/3/2024 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/9/2024 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/19/2024 | Inspire Medical Systems | INSP | New Coverage | Overweight (N/A) |
199.23 (71.11) |
-64.31% | Details | |
| 3/8/2024 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/4/2023 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/8/2023 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/3/2023 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/13/2023 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/6/2023 | Penumbra | PEN | New Coverage | Equalweight (N/A) |
262.10 (324.39) |
23.77% | Details |
